NIP
ACAD icon

Nicholas Investment Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Nicholas Investment Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-117,087
Closed -$3.73M – 269
2016
Q3 		$3.73M Sell
117,087
-9,000
-7% -$305K 0.25% 162
2016
Q2 		$4.09M Buy
+126,087
New +$4.22M 0.28% 132
2016
Q1 		– Sell
-55,254
Closed -$1.97M – 299
2015
Q4 		$1.97M Buy
+55,254
New +$1.95M 0.14% 257
2015
Q3 		– Sell
-43,964
Closed -$1.84M – 295
2015
Q2 		$1.84M Sell
43,964
-14,059
-24% -$544K 0.12% 272
2015
Q1 		$1.89M Buy
+58,023
New +$1.99M 0.12% 261

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return